Retinopathy screening in individuals with type 2 diabetes: Who, how, how often, and at what cost - An epidemiologic review

Optometry

Volumn 76, Issue 11, 2005, Pages 636-646

  Swanson, Mark ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cost benefit; Diabetic retinopathy; Screening; Type 2 diabetes

Indexed keywords

EID: 29344437575     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.optm.2005.08.019     Document Type: Article

References (83)

1. The Eye Disease Prevalence Research Group. National Institutes of Health. Vision loss will increase as Americans age. http://www.nei.nih.gov/news/ pressreleases/041204.asp. Last accessed September 28, 2004.
2. Anonymous. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial. N Engl J Med 2000;342(6):381-9.
3. Anonymous. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 1985;103:1796-1806.
4. Anonymous. Preliminary report on effects of photocoagulation therapy. The Diabetic Retinopathy Study Research Group. Am J Ophthalmol 1976;81:383-96.
5. Anonymous. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial. Diabetic Retinopathy Vitrectomy Study report 2. The Diabetic Retinopathy Vitrectomy Study Research Group. Arch Ophthalmol 1985;103(11):1644-52.
6. Kohner EM, Aldigton SJ, Stratton IM, et al. United Kingdom Prospective Diabetes Study, 30: Diabetic retinopathy at diagnosis of non-insulin dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 1998;116(3):297-303.
7. The Expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; suppl 1:s5-s20.
8. The National Screening Committee. Preservation of sight in diabetes: a risk reduction programme, http://www.diabetic-retinopathy.screening.nhs.uk/. Last accessed April 10, 2004.
9. Klein R, Klein BE, Moss SE, et al. The Wisconsin Study of the Epidemiology of Diabetic Retinopathy III. Prevalence and risk of diabetes when the age of diagnosis is 30 years or more. Arch Ophthalmol 1984;102:527-32.
10. Brown JB, Pedula KL, Summers KH. Diabetic retinopathy: contemporary prevalence in a well-controlled population. Diabetes Care 2003;26(9):2637-42.
11. Vijan S, Hofer TP, Hayward RA. Cost utility of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA 2000;283:889-96.
12. California Healthcare foundation/American Geriatrics Society panel on improving care for elders with diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatric Soc 2003; 51(5)suppl:s265-s80.
13. Fong DS, Aiello L, Gardner TW, et al. Diabetic retinopathy. Diabetes Care 2003;26(suppl 1):s99-s102.
14. American Academy of Ophthalmology Retina Panel, Preferred Practice Patterns Committee. Diabetic retinopathy. http://www.guideline.gov/summary/ summary.aspx?doc_id=4350. Last accessed October 4, 2004.
15. Optometric clinical care guideline, care of the patient with diabetes mellitus, 3rd Ed. 2002. http://www.aoa.org/eweb/Documents/CPG-3.pdf. Last accessed October 4, 2004.
16. Aiello LP, Gardner TW, King GL, et al. Diabetic retinopathy. Diabetes Care 1998;21:143-56.
17. Sanchez-Thorin JC. The epidemiology of diabetes and diabetic retinopathy. Int Ophthalmol Clin 1999;38(2):11-8.
18. Gruber W, Lander T, Leese B, et al. Diabetes Health Economics Study Group. The economics of diabetes and diabetic care. Geneva: International Diabetes Foundation and World Health Organization, 1993.
19. Wilson PW, Gundy S. The metabolic syndrome practical guide to treatment: part 1. Circulation 2003;108:1422-6.
20. MacDonald KG. Overview of the epidemiology of obesity and the early history of procedures to remedy morbid obesity. Arch Surg 2003;138(4):357-60.
21. Rocchini AP. Childhood obesity and a diabetes epidemic. N Engl J Med 2002;346(11):854-5.
22. Benjamin SM, Rolka DB, Valdez R, et al. Estimated number of adults with prediabetes in the U.S. 2000. Diabetes Care 2000;26:645-9.
23. Henricsson M, Nystrom L, Blohme G, et al. The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care 2003;26(2):349-54.
24. Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis Diabetologia 2001;44(2):156-63.
25. Cohen O, Norymberg K, Neumann E, et al. Complication free duration and risk of development of retinopathy in elderly diabetic patients. Arch Intern Med 1998;158:641-4.
26. Stefansson E, Bek T, Porta M, et al. Screening and prevention of diabetic blindness. Acta Ophthalmol Scand 2000;78:374-85.
27. Kristinsson JK. Diabetic retinopathy Screening and prevention of blindness. A doctoral thesis. Acta Ophthalmol Scand 1997;223(Suppl):1-76.
28. Moss SE, Klein R, Kessler SD, et al. Comparison between ophthalmoscopy and fundus photography in determining the severity of diabetic retinopathy. Ophthalmology 1985;92:62-7.
29. Anonymous. Microvascular and acute complications in IDDM patients: The EURODIAB IDDM Complications Study. Diabetologia 1994;37:279-85.
30. Kinyoun JL, Martin DC, Fujimoto WY, et al. Ophthalmoscopy versus fundus photographs for detecting and grading diabetic retinopathy. Inv Ophthalmol Vis Sci 1992;3:1888-93.
31. Palmberg P, Smith M, Waltman S, et al. The natural history of insulin dependent juvenile-onset diabetes. Ophthalmology 1981;88:613-8.
32. Harding SP, Broadbent DM, Neoh C, et al. Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool diabetic eye study. Br J Med 1995;311:1131-5.
33. Lin DY, Blumenkrantz MS, Brothers RJ, et al. The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol 2002;134:204-13.
34. Detection of diabetic macular edema: ophthalmoscopy versus photography. Early treatment diabetic retinopathy study report number 5. Ophthalmology 1989;96:746-51.
35. Kleinstein RN, Roseman JM, Herman WH, et al. Detection of diabetic retinopathy by optometrists. J Am Optom Assoc 1987;58:879-82.
36. Burnett S, Hurwitz B, Davey J, et al. The implementation of prompted retinal screening for diabetic eye disease by accredited optometrists in an inner city district of North London: a quality of care study. Diabet Med 1998;15(Suppl 3):538-43.
37. Prasad S, Kamath GG, Jones K, et al. Effectiveness of optometrist screening for diabetic retinopathy using slit-lamp biomicroscopy. Eye 2001;15(Pt 5):595-601.
38. Olson JA, Strachan FM, Hipwell JH, et al. A comparative evaluation of digital imaging, retinal photography and optometrist examination in screening for diabetic retinopathy. Diabet Med 2003;20(7):528-34.
39. Taylor DJ, Fisher J, Jacob J, et al. The use of digital cameras in a mobile retinal screening environment. Diabet Med 1999;16:680-6.
40. Liesenfeld B, Kohner E, Piehlmeier W, et al. A telemedical approach to the screening of diabetic retinopathy: digital fundus photography. Diabetes Care 2000;23(3):345-8.
41. Scanlon PH, Malhotra R, Thomas G, et al. The effectiveness of screening for diabetic retinopathy by digital imaging photography and technician ophthalmoscopy. Diabet Med 2003;20:467-74.
42. Bursell SE, Cavallerano JD, Cavallerano AA, et al. Stereo nonmydriatic digital-video color retinal imaging compared with early treatment diabetic retinopathy study seven standard field 35-mm stereo color photos for determining level of diabetic retinopathy. Ophthalmology 2001;108(3):572-85.
43. Rudnisky CJ, Hinz BJ, Tennant MT, et al. High-resolution stereoscopic digital fundus photography versus contact lens biomicroscopy for the detection of clinically significant macular edema. Ophthalmology 2002;109(2):267-74.
44. Penman AD, Saaddine JB, Hegazy M, et al. Screening for diabetic retinopathy: the utility of nonmydriatic retinal photography in Egyptian adults. Diabet Med 1998;15:783-7.
45. Boucher MC, Gresset JA, Angioi K, et al. Effectiveness and safety of screening for diabetic retinopathy with two nonmydriatic digital images compared with the seven standard stereoscopic photographic fields. Can J Ophthalmol 2003;38(7):557-68.
46. Herbert HM, Jordan K, Flanagan DW. Is screening with digital imaging using one retinal view adequate? Eye 2003;17(4):497-500.
47. Gibbins RL, Owens DR, Allen JC, et al. Practical application of the European Field Guide in screening for diabetic retinopathy by using ophthalmoscopy and 35mm retinal slides. Diabetologia 1998;41:59-64.
48. Agrawal A, McKibbin MA. Technical failure in photographic screening. Diabet Med 2003;20:777.
49. Diamond JP, McKinnon M, Barry C, et al. Non-mydriatic fundus photography: a viable alternative to fundoscopy for identification of diabetic retinopathy in an Aboriginal population in rural Western Australia. Aust NZ J Ophthalmol 1998;26(2):109-15.
50. George LD, Leverton C, Young S, et al. Can digitised colour 35mm transparencies be used to diagnose diabetic retinopathy. Diabet Med 1997;14: 970-3.
51. Basu A, Kamal AD, Illahi W, et al. Is digital compression acceptable within diabetic retinopathy screening. Diabet Med 2003:20:766-71.
52. Newsom RS, Clover A, Costen MT, et al. Effect of digital image compression on screening for diabetic retinopathy. Br J Ophthalmol 2001:85(7):799-802.
53. Zeimer R, Zou S, Meeder T, et al. A fundus camera dedicated to the screening of diabetic retinopathy in the primary-care physician's office. Invest Ophthalmol Vis Sci 2002;43(5):1581-7.
54. New Product: The DigiScope. http://www.diabetesincontrol.com/issue203/np. shtml. Last accessed September 27, 2004.
55. Vanderbilt Imaging Center, http://www.microsoft.com/resources/ casestudies/CaseStudy.asp?CaseStudyID=1537957. Last accessed September 28, 2004.
56. Screening for Diabetic Retinopathy. http://www.hap.org/gfx/content/ v3_i2hmo.pdf. Last accessed September 28, 2004.
57. Insurance coverage of telemedicine grows, but payments subject to limits. Physicians Compensation Reports, August 2002. http://www.findarticles.com/p/ articles/mi_m0FBW/is_8_3/ai_90654826. Last accessed September 28, 2004.
58. Larsen M, Godt J, Larsen N, et al. Automated detection of diabetic retinopathy in a fundus photographic screening population. Invest Ophthalmol Vis Sci 2003;44(2):761-6.
59. Osareh A, Mirmehdi M, Thomas, B, et al. Automated identification of diabetic retinal exudates in digital colour images. Br J Ophthalmol 2003;87:1220-3.
60. Ege BM, Hejlesen OK, Larsen OV, et al. Screening for diabetic retinopathy using computer based image analysis and statistical classification. Comput Methods Programs BioMed 2000;62:165-72.
61. Chiang YP, Bassi LJ, Javitt JC. Federal budgetary cost of blindness. Milbank Q 1992;70:319-40.
62. Laupacis A, Feeny D, Detsky AS, et al. How attractive does new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 1992;146:473-81.
63. Savolainen EA, Lee QP. Diabetic retinopathy: need and demand for photocoagulation and its cost-effectiveness: evaluation of services in the United Kingdom. Diabetologia 1982;23:138-40.
64. Foulds WS, McCuish A, Barrie T, et al. Diabetic retinopathy in the West of Scotland: its detection and prevalence, and the cost-effectiveness of a proposed screening programme. Health Bull 1983;41:318-26.
65. Javitt JC, Canner JK, Sommer A. Cost effectiveness of current approaches to the control of retinopathy in type 1 diabetics. Ophthalmology 1989;96:255-64.
66. Javitt JC, Canner JK, Frank RG, et al. Detecting and treating retinopathy in patients with type 1 diabetes mellitus: a health policy model. Ophthalmology 1990;97:483-95.
67. Javitt JC, Aiello LP, Bassi LJ, et al. Detecting and treating retinopathy in patients with type I diabetes mellitus. Savings associated with improved implementation of current guidelines. Ophthalmology 1991; 98(10):1565-73.
68. Dasbach EJ, Fryback DG, Newcombe PA, et al. Cost effectiveness of strategies for detecting diabetic retinopathy. Med Care 1991;29:20-39.
69. Lairson DR, Pugh JA, Kapadia AS, et al. Cost-effectiveness of alternative methods of screening for diabetic retinopathy. Diabetes Care 1992;15:1369-77.
70. Klonoff DC, Swartz DM. An economic analysis of interventions for diabetes. Diabetes Care 2000;23:390-404.
71. Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 1996;124:164-9.
72. Taylor TN, Chrischilles A. Economic evaluation of interventions in endocrinology. Endocrinol Metab Clin North Am 1997;26:67-87.
73. Morse AR, Yatzkan E, Berberich B, et al. Acute care hospital utilization by patients with visual impairment. Arch Ophthalmol 1999;117(7):943-9.
74. Aditya BS, Sharma JC, Allen SC, et al. Predictors of a nursing home placement from a non-acute geriatric hospital. Clin Rehabil 2003;17(1):108-13.
75. Ivers RQ. Norton R, Cumming RG, et al. Visual impairment and risk of hip fracture. Am J Epidemiol 2000;152(7):633-9.
76. Maberley D, Walker H, Koushik A, et al. Screening for diabetic retinopathy in James Bay, Ontario: a cost-effectiveness analysis. CMAJ 2003;168(2):160-4.
77. Bjorvig S, Johansen MA, Fossen K. An economic analysis of screening for diabetic retinopathy. J Telemed Telecare 2002;8(1):32-5.
78. James M, Turner DA, Broadbent DM, et al. Cost effectiveness of screening for sight threatening diabetic eye disease. BMJ 2000;320(7250):1627-31.
79. Thompson JW, Bost J, Ahmed F, et al. The NCQA's quality compass: evaluating man aged care in the United States. Health Aff 1998;17:152-8.
80. Diabetes Physician Recognition Program. http://www.ncqa.org/dprp/dprpfaq. htm#Diabetes%20Physician%20Recognition%20Program%20Measures%20for%20Adult %20Patients. Last accessed October 1, 2004.
81. Weiner JP, Parente ST, Garnick DW, et al. Variation in office based quality. A claims based profile of care provided to Medicare patients with diabetes. JAMA 1995;273:1503-8.
82. Bresnick GH, Mukamel DB, Dickinson JC, et al. A screening approach to the surveillance of patients with diabetes for the presence of vision threatening retinopathy. Ophthalmology 2000;107:19-24.
83. Javitt JC. How often should patients with diabetes be screened for retinopathy? JAMA 2000;284(4):437-8.